The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
If I’m the CEO Of AstraZeneca first thing I will do I will delists it from uK Stockmarket and only listed in USA .
Yesterday the AstraZeneca share price in UK was dow despite the good news and it was up in USA .
Pfizer with the same news like AstraZeneca share price jumped to all time high in USA but in AstraZeneca in UK AstraZeneca went down .
Now I understand why BHP will be delisting from UK Stockmarket .
AstraZeneca had the same news like Pfizer regarding Astrazeneca - Neutralising Antibody Levels Against Omicron
Following A Third Dose Boost Of Vaxzevria Were Broadly Similar
To Levels Achieved After Two Doses Against Delta Variant AstraZeneca Says Evusheld Long – Acting Antibody Combo Retains Neutralising Activity Against Omicron
But when Pfizer when had this news the share price jumped to new high and it is going up everyday now but unfortunately AstraZeneca UK Stockmarket investors punish AstraZeneca for the the good news as usual and sent the share price down , , where Chris Santa rally ??
AstraZeneca Plc Says Vaxzevria Significantly Boosted Antibody Levels Against Omicron
23 Dec 2021 18:31
Dec 23 (Reuters) – AstraZeneca PLC :
Astrazeneca - Vaxzevria Significantly Boosted Antibody
Levels
Against Omicron
Astrazeneca - University Of Oxford Study Supports Use Of
Vaxzevria As Third Dose Booster Against Omicron
Astrazeneca - Neutralising Antibody Levels Against Omicron
Following A Third Dose Boost Of Vaxzevria Were Broadly Similar
To Levels Achieved After Two Doses Against Delta Variant
ASTRAZENECA: AstraZeneca Plc said it was working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant-specific vaccine. ...
U.S. FDA authorizes use of AstraZeneca COVID-19 antibody ****tail
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-authorizes-astrazenecas-covid-19-antibody-drug-2021-12-08/
Pfizer, BioNTech fall as study shows vaccine offers partial immunity to Omicron
08 Dec 2021 21:01
* Shares of vaccine makers Pfizer Inc and BioNTech drop 3% and 5.1% premarket, respectively
* An early study in South Africa suggests that the COVID-19 vaccine developed by PFE and BNTX offers only partial protection against the Omicron coronavirus variant...
* Study also suggests booster doses of the vaccine could provide better protection
Chris1308,
I agree with your post , I suffered with my investment in UK Stockmarket , special with AstraZeneca .
most of the time when AstraZeneca had good announcement to the market ,instead of share price going up it went down big , it had happened more than one times ,so I start to be afraid if the company gets good news to the market .
Uk market is been manipulated and it is need strong regulation .
South African medical association says Omicron variant causes 'mild disease'
https://timesofindia.indiatimes.com/world/rest-of-world/south-african-medical-association-says-omicron-variant-causes-mild-disease/articleshow/87949404.cms
AstraZeneca Plc may offer longer-lasting immunity than other vaccines, scientists have said amid claims that the jab has helped Britain avoid the latest Covid-19 wave in Europe. https://bit.ly/3CQuJWx